文献速递耳科与耳神经

眩晕与突发性感音神经性聋听力预后的关联:系统评价与荟萃分析

Association of Vertigo With Hearing Outcomes in Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2018-01-01

该系统评价与荟萃分析纳入10项研究共4814例突发性感音神经性聋患者,其中伴眩晕组1709例、不伴眩晕组3105例。伴眩晕组听力恢复率为42.13%,不伴眩晕组为60.29%;眩晕与更差的听力恢复显著相关(OR 2.22,95%CI 1.54-3.20,I²=74%)。亚组分析显示,接受鼓室内皮质类固醇治疗的患者中未观察到眩晕与预后的关联(OR 1.78,95%CI 0.64-4.94,I²=70%)。

要点

  • 伴眩晕的突发性感音神经性聋患者听力恢复率低于不伴眩晕者(42.13% vs 60.29%)。
  • 眩晕与更差的听力恢复显著相关(OR 2.22,95%CI 1.54-3.20)。
  • 鼓室内皮质类固醇亚组中眩晕与听力预后无显著关联。

核心结论

  • 现有证据表明眩晕可能与突发性感音神经性聋患者听力恢复呈负相关,但接受鼓室内皮质类固醇治疗的亚组除外。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Web of Science和Embase从1973年9月26日至2017年9月26日的英文文献。
  • 纳入10项研究共4814例患者,伴眩晕组1709例,不伴眩晕组3105例,纳入研究的新卡斯尔-渥太华量表评分均大于7。

主要发现

  • 伴眩晕组听力恢复率为42.13%,不伴眩晕组为60.29%。
  • 眩晕与更差的听力恢复显著相关(OR 2.22,95%CI 1.54-3.20,I²=74%)。
  • 采用Siegel标准和全身皮质类固醇治疗的亚组分析结果相似。
  • 接受鼓室内皮质类固醇治疗的亚组中未观察到眩晕与预后的关联(OR 1.78,95%CI 0.64-4.94,I²=70%)。

关键数值与推荐

  • 听力恢复率:伴眩晕组42.13%,不伴眩晕组60.29%。
  • 眩晕与听力恢复的关联:OR 2.22(95%CI 1.54-3.20,I²=74%)。
  • 鼓室内皮质类固醇亚组:OR 1.78(95%CI 0.64-4.94,I²=70%)。
  • 研究质量评估采用新卡斯尔-渥太华量表,评分范围0-9分,≥6分为高质量研究。

临床怎么用

  • 对伴眩晕的突发性感音神经性聋患者应预期更差的听力恢复。
  • 鼓室内皮质类固醇注射可能对伴眩晕的突发性感音神经性聋更有效。
  • 未来需研究治疗眩晕是否有助于突发性感音神经性聋的恢复。

局限性

  • 纳入研究存在异质性(I²=74%)。
  • 鼓室内皮质类固醇亚组样本量有限,置信区间较宽。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sudden sensorineural hearing loss (SSHL) accompanied by vertigo may portend a negative prognosis in the hearing outcome. OBJECTIVE: To investigate the association of vertigo with prognosis of hearing variables in SSHL. DATA SOURCES: A literature search of eligible studies was performed in PubMed, Web of Science, and Embase from September 26, 1973, through September 26, 2017. Studies published in English were retrieved with no restrictions on the date of publication. References were identified by screening the proceedings of relevant reviews, and annual meeting and other correlative papers were scanned manually for enrollment. STUDY SELECTION: All original research studies and retrospective or prospective studies focusing on the role of vertigo in the prognosis for the hearing outcome of SSHL were systematically retrieved. Studies that did not include data regarding the association between the rate of hearing recovery and vertigo were excluded, as were reviews, comments, case reports, editorials, letters, and practice guidelines. DATA EXTRACTION AND SYNTHESIS: Data were extracted and evaluated by 2 researchers. Data extracted included research type, number of participants with or without vertigo, treatment regime, definition of pure-tone average, criteria for hearing improvement, and length of follow-up. The quality of included studies was evaluated using the Newcastle-Ottawa Scale (scores range from 0-9, with a score of ≥6 indicating a high-quality study). The data were synthesized in Mantel-Haenszel models; the aggregate results were estimated in forest plots. MAIN OUTCOMES AND MEASURES: Association of vertigo with the prognosis for the hearing outcome of SSHL. RESULTS: Of the 4814 unique patients identified in 10 studies, 1709 were included in the SSHL group with vertigo and 3105 were included in SSHL group without vertigo. The Newcastle-Ottawa Scale score of each study selected was greater than 7. The recovery rate of hearing was 42.13% in the group with vertigo, compared with 60.29% in the group without vertigo. Vertigo was significantly associated with a worse hearing recovery (odds ratio, 2.22; 95% CI, 1.54-3.20; I2 = 74%). Similar results were obtained in subgroup analyses of the grading system using the Siegel criteria and systemic corticosteroid therapy. However, no association of vertigo with the prognosis of SSHL was observed within the subgroup receiving intratympanic corticosteroids (odds ratio, 1.78; 95% CI, 0.64-4.94; I2 = 70%). CONCLUSIONS AND RELEVANCE: Current evidence revealed that vertigo may be negatively associated with hearing recovery in patients with SSHL, except in a subgroup that received intratympanic corticosteroids. Corticosteroid injection may be more effective for treatment of SSHL accompanied by vertigo; future studies are needed to determine whether treatment of vertigo might contribute to the recovery of SSHL.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Yu H, Li H. Association of Vertigo With Hearing Outcomes in Patients With Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29931169. doi:10.1001/jamaoto.2018.0648

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。